HCWB ▲ +18.3% - HCW Biologics Inc.
$HCWB - HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors
09-OCT-2026 09:00 AM ET
Share this post
More filings for $HCWB
HCWB ▼ -12.9% - HCW Biologics Inc.Sep 24, 2026HCWB ▼ -2.0% - HCW Biologics Inc.Sep 8, 2026HCWB ▲ +3.5% - HCW Biologics Inc.Sep 2, 2026
View full $HCWB filing history →💬 Comments
Loading comments…
Leave a comment
